FDA Approved: LUMRYZ — Original Application (Avadel CNS Pharmaceuticals, LLC)

View source ↗

Summary

FDA approved LUMRYZ (sodium oxybate) from Avadel CNS Pharmaceuticals, LLC as an original application (NDA214755) for the treatment of narcolepsy.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Narcolepsy

Drugs mentioned

• LUMRYZ (Sodium oxybate)

Snippet

ORIG AP for LUMRYZ (SODIUM OXYBATE)